EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma proteome perturbation for CMV DNAemia in kidney transplantation

Tara K Sigdel iD, Patrick Boada, Maggie Kerwin, Priyanka Rashmi, David Gjertson, Maura Rossetti, Swastika Sur, Dane Munar, James Cimino, Richard Ahn, Harry Pickering, Subha Sen und 8 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0285870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Tara K Sigdel und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California San Francisco, San Francisco, CA, United States of America. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections, Serpins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) infection, either de novo or as reactivation after allotransplantation and chronic immunosuppression, is recognized to cause detrimental alloimmune effects, inclusive of higher susceptibility to graft rejection and substantive impact on chronic graft injury and reduced transplant survival. To obtain further insights into the evolution and pathogenesis of CMV infection in an immunocompromised host we evaluated changes in the circulating host proteome serially, before and after transplantation, and during and after CMV DNA replication (DNAemia), as measured by quantitative polymerase chain reaction (QPCR).

Methods

LC-MS-based proteomics was conducted on 168 serially banked plasma samples, from 62 propensity score-matched kidney transplant recipients. Patients were stratified by CMV replication status into 31 with CMV DNAemia and 31 without CMV DNAemia. Patients had blood samples drawn at protocol times of 3- and 12-months post-transplant. Additionally, blood samples were also drawn before and 1 week and 1 month after detection of CMV DNAemia. Plasma proteins were analyzed using an LCMS 8060 triple quadrupole mass spectrometer. Further, public transcriptomic data on time matched PBMCs samples from the same patients was utilized to evaluate integrative pathways. Data analysis was conducted using R and Limma.

Results

Samples were segregated based on their proteomic profiles with respect to their CMV Dnaemia status. A subset of 17 plasma proteins was observed to predict the onset of CMV at 3 months post-transplant enriching platelet degranulation (FDR, 4.83E-06), acute inflammatory response (FDR, 0.0018), blood coagulation (FDR, 0.0018) pathways. An increase in many immune complex proteins were observed at CMV infection. Prior to DNAemia the plasma proteome showed changes in the anti-inflammatory adipokine vaspin (SERPINA12), copper binding protein ceruloplasmin (CP), complement activation (FDR = 0.03), and proteins enriched in the humoral (FDR = 0.01) and innate immune responses (FDR = 0.01).

Conclusion

Plasma proteomic and transcriptional perturbations impacting humoral and innate immune pathways are observed during CMV infection and provide biomarkers for CMV disease prediction and resolution. Further studies to understand the clinical impact of these pathways can help in the formulation of different types and duration of anti-viral therapies for the management of CMV infection in the immunocompromised host.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCytomegalovirus InfectionsSerpinsHumansCytomegalovirusProteomeProteomicsDNA, Viral

Substanzen

ProteomeDNA, ViralSERPINA12 protein, humanSerpins

Autor:innen und Institutionen

  • Department of Surgery, University of California San Francisco, San Francisco, CA, United States of America.
  • Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.
  • Department of Microbiology and Immunology, University of California Los Angeles, Los Angeles, CA, United States of America.
  • Department of Pathology, Harvard Medical School, Boston, MA, United States of America.
  • Department of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.

ORCID-Profile: Tara K Sigdel, Rajesh Parmar, Minnie M Sarwal

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Sigdel, T. K., Boada, P., Kerwin, M., Rashmi, P., Gjertson, D., Rossetti, M., Sur, S., Munar, D., Cimino, J., Ahn, R., Pickering, H., Sen, S., Parmar, R., Fatou, B., Steen, H., Schaenman, J., Bunnapradist, S., Reed, E. F., Sarwal, M. M., & CMV Systems Immunobiology Group (2023). Plasma proteome perturbation for CMV DNAemia in kidney transplantation. PLOS ONE. https://doi.org/10.1371/journal.pone.0285870

Vancouver

Sigdel TK, Boada P, Kerwin M, Rashmi P, Gjertson D, Rossetti M, et al. Plasma proteome perturbation for CMV DNAemia in kidney transplantation. PLOS ONE. 2023. doi:10.1371/journal.pone.0285870

BibTeX
@article{Sigdel2023,
  author = {Sigdel, Tara K and Boada, Patrick and Kerwin, Maggie and Rashmi, Priyanka and Gjertson, David and Rossetti, Maura and Sur, Swastika and Munar, Dane and Cimino, James and Ahn, Richard and Pickering, Harry and Sen, Subha and Parmar, Rajesh and Fatou, Benoit and Steen, Hanno and Schaenman, Joanna and Bunnapradist, Suphamai and Reed, Elaine F and Sarwal, Minnie M and CMV Systems Immunobiology Group, CMV Systems Immunobiology Group},
  title = {Plasma proteome perturbation for CMV DNAemia in kidney transplantation},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0285870}
}
Kostenlos starten →